Therapy of Lymphoma/Leukemia with Monoclonal Antibodies

Arash Ash Alizadeh

Modeling the Molecular Determinants of Induced Anti-Tumor Immune Responses in Mantle Cell Lymphoma

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Stanley R. Riddell

Targeted therapy of B cell malignances with CAR-T cells of defined composition

Non-Hodgkin lymphoma Leukaemia

Andrew G Myers

Synthesis and Study of Natural and Non-natural Antiproliferative Agents

Leukaemia

Hematology and hematologic malignancies Pathology

Peng Huang

ROS, Redox Regulation and Novel Targets for Cancer Therapy

Leukaemia

Manoj Menon

AMC PROTOCOL #075: A Sequential Phase I/Randomized Phase II Trial of Vorinostat and Risk-Adapted Chemotherapy with Rituximab in HIV-Related B-Cell Non-Hodgkin’s Lymphoma. A Trial of the AIDS Malignancy Consortium (AMC)

Hodgkin lymphoma

Hematology and hematologic malignancies

Melinda Sue Butschkovacic

Fanconi Anemia as a Model for Susceptibility to Human Papillomavirus Infection

Non-Hodgkin lymphoma Hodgkin lymphoma

Corey Casper

Impact of HIV and HHV-8 Co-Infection on Antiretroviral Therapy Efficacy in Africa

Non-Hodgkin lymphoma

Theodore S Jardetzky

Inhibitors of the Epstein-Barr Virus Entry Machinery

Hodgkin lymphoma Non-Hodgkin lymphoma

Brenda Marie Sandmaier

Alpha Radioimmunotherapy for Lymphoma Treatment

Non-Hodgkin lymphoma Hodgkin lymphoma